Table 2. SAR: Introduction of R1 Substituents Underneath the Nucleotide Binding Loop and Combination with a N-Methylpiperazine Moiety.
compd | IRAK4 IC50 (nM)a | A | R1 | R2 |
---|---|---|---|---|
7 | 111 | N | Me | benzoyl |
8 | 83 | N | F | benzoyl |
9 | 51 | N | Cl | benzoyl |
10 | 6 | N | OEt | benzoyl |
11 | 13 | N | OiPr | benzoyl |
12 | 961 | N | F | Me |
13 | 126 | N | Cyano | Me |
14 | 57 | N | OMe | Me |
15 | 38 | N | OCF3 | Me |
16 | 5 | N | OEt | Me |
17 | 4 | N | OiPr | Me |
18 | 3 | N | cyclopropylmethoxy | Me |
19 | 12 | O | OMe | |
20 | 12 | O | OEt |
Biochemical potency of IRAK4 inhibition (1 mM ATP).